Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line.
BACKGROUND
For many promising target cells (e.g.: haematopoeitic progenitors), the susceptibility to standard adeno-associated viral (AAV) vectors is low. Advancements in vector development now allows the generation of target cell-selected AAV capsid mutants.


METHODS
To determine its suitability, the method was applied on a chronic myelogenous leukaemia (CML) cell line (K562) to obtain a CML-targeted vector and the resulting vectors tested on leukaemia, non-leukaemia, primary human CML and CD34+ peripheral blood progenitor cells (PBPC); standard AAV2 and a random capsid mutant vector served as controls.


RESULTS
Transduction of CML (BV173, EM3, K562 and Lama84) and AML (HL60 and KG1a) cell lines with the capsid mutants resulted in an up to 36-fold increase in CML transduction efficiency (K562: 2-fold, 60% +/- 2% green fluorescent protein (GFP)+ cells; BV173: 9-fold, 37% +/- 2% GFP+ cells; Lama84: 36-fold, 29% +/- 2% GFP+ cells) compared to controls. For AML (KG1a, HL60) and one CML cell line (EM3), no significant transduction (<1% GFP+ cells) was observed for any vector. Although the capsid mutant clone was established on a cell line, proof-of-principle experiments using primary human cells were performed. For CML (3.2-fold, mutant: 1.75% +/- 0.45% GFP+ cells, p = 0.03) and PBPC (3.5-fold, mutant: 4.21% +/- 3.40% GFP+ cells) a moderate increase in gene transfer of the capsid mutant compared to control vectors was observed.


CONCLUSIONS
Using an AAV random peptide library on a CML cell line, we were able to generate a capsid mutant, which transduced CML cell lines and primary human haematopoietic progenitor cells with higher efficiency than standard recombinant AAV vectors.
Stiefelhagen
Marius
M
Department G402, Pharmacology of Cancer Treatment, German Cancer Research Center, INF 280, D-69120, Heidelberg, Germany. mstiefelhagen@gmail.com
Sellner
Leopold
L
Kleinschmidt
Jürgen A
JA
Jauch
Anna
A
Laufs
Stephanie
S
Wenz
Frederik
F
Zeller
W Jens
WJ
Fruehauf
Stefan
S
Veldwijk
Marlon R
MR
Science. 2001 Aug 3;293(5531):876-80
11423618
Nat Biotechnol. 2003 Sep;21(9):1040-6
12897791
Nat Med. 1999 Jan;5(1):78-82
9883843
J Virol. 1997 Nov;71(11):8262-7
9343178
Blood. 1997 Mar 15;89(6):2167-75
9058741
Blood. 1999 Mar 15;93(6):1882-94
10068661
Nat Med. 1999 Jan;5(1):71-7
9883842
Mol Ther. 2003 Jul;8(1):151-7
12842438
Mol Ther. 2001 Sep;4(3):174-81
11545607
Hum Gene Ther. 2005 Jul;16(7):792-8
16000061
Pediatr Res. 2005 Dec;58(6):1143-7
16306183
Hum Gene Ther. 1997 Nov 1;8(16):1911-20
9382957
Hum Gene Ther. 2004 Dec;15(12):1207-18
15684697
Curr Gene Ther. 2005 Jun;5(3):311-21
15975008
Hum Gene Ther. 2003 Jul 20;14(11):1079-88
12885347
Hum Gene Ther. 1998 Mar 20;9(5):695-706
9551617
Blood. 2002 May 1;99(9):3472-5
11964322
Cancer Cell. 2002 Aug;2(2):117-25
12204532
Nat Genet. 1996 Apr;12(4):368-75
8630489
N Engl J Med. 1999 Jul 15;341(3):164-72
10403855
Natl Med J India. 2006 Sep-Oct;19(5):255-63
17203680
Gene Ther. 2000 Feb;7(3):183-95
10694794
J Virol. 1998 Feb;72(2):1438-45
9445046
J Virol. 2005 Jan;79(1):609-14
15596854
Chromosome Res. 2002;10(3):223-32
12067211
J Virol. 1996 May;70(5):3227-34
8627803
Gene Ther. 2003 Jun;10(11):955-63
12756416
Radiother Oncol. 2004 Sep;72(3):341-50
15450734
Eur J Cancer. 1999 Jul;35(7):1136-42
10533460
Mol Ther. 2002 Aug;6(2):272-8
12349826
Blood. 2003 Apr 15;101(8):2963-72
12515715
Lung Cancer. 2004 Nov;46(2):179-86
15474666
Nature. 2000 Jul 6;406(6791):82-6
10894546
Blood. 2004 Feb 15;103(4):1253-60
14551134
Mol Ther. 2001 Jun;3(6):964-75
11407911
Gene Ther. 2003 Jun;10(11):964-76
12756417
Cancer Gene Ther. 2000 Apr;7(4):597-604
10811478
J Virol. 1997 Mar;71(3):1776-83
9032306
Cancer Gene Ther. 2004 Aug;11(8):577-84
15280909
Nat Med. 1996 May;2(5):561-6
8616716
Nat Genet. 2000 Mar;24(3):257-61
10700178
Hum Gene Ther. 2005 Jun;16(6):699-710
15960601
Gene Ther. 1999 Jun;6(6):973-85
10455399
Science. 2003 Oct 17;302(5644):415-9
14564000
Blood. 2004 Dec 1;104(12):3445-53
15292064